Plasminogen activator inhibitor-2

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
serpin peptidase inhibitor, clade B (ovalbumin), member 2
Identifiers
Symbol SERPINB2
Alt. Symbols PLANH2, PAI2
Entrez 5055
HUGO 8584
OMIM 173390
RefSeq NM_002575
UniProt P05120
Other data
Locus Chr. 18 q21.3

WikiDoc Resources for

Plasminogen activator inhibitor-2

Articles

Most recent articles on Plasminogen activator inhibitor-2

Most cited articles on Plasminogen activator inhibitor-2

Review articles on Plasminogen activator inhibitor-2

Articles on Plasminogen activator inhibitor-2 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Plasminogen activator inhibitor-2

Images of Plasminogen activator inhibitor-2

Photos of Plasminogen activator inhibitor-2

Podcasts & MP3s on Plasminogen activator inhibitor-2

Videos on Plasminogen activator inhibitor-2

Evidence Based Medicine

Cochrane Collaboration on Plasminogen activator inhibitor-2

Bandolier on Plasminogen activator inhibitor-2

TRIP on Plasminogen activator inhibitor-2

Clinical Trials

Ongoing Trials on Plasminogen activator inhibitor-2 at Clinical Trials.gov

Trial results on Plasminogen activator inhibitor-2

Clinical Trials on Plasminogen activator inhibitor-2 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Plasminogen activator inhibitor-2

NICE Guidance on Plasminogen activator inhibitor-2

NHS PRODIGY Guidance

FDA on Plasminogen activator inhibitor-2

CDC on Plasminogen activator inhibitor-2

Books

Books on Plasminogen activator inhibitor-2

News

Plasminogen activator inhibitor-2 in the news

Be alerted to news on Plasminogen activator inhibitor-2

News trends on Plasminogen activator inhibitor-2

Commentary

Blogs on Plasminogen activator inhibitor-2

Definitions

Definitions of Plasminogen activator inhibitor-2

Patient Resources / Community

Patient resources on Plasminogen activator inhibitor-2

Discussion groups on Plasminogen activator inhibitor-2

Patient Handouts on Plasminogen activator inhibitor-2

Directions to Hospitals Treating Plasminogen activator inhibitor-2

Risk calculators and risk factors for Plasminogen activator inhibitor-2

Healthcare Provider Resources

Symptoms of Plasminogen activator inhibitor-2

Causes & Risk Factors for Plasminogen activator inhibitor-2

Diagnostic studies for Plasminogen activator inhibitor-2

Treatment of Plasminogen activator inhibitor-2

Continuing Medical Education (CME)

CME Programs on Plasminogen activator inhibitor-2

International

Plasminogen activator inhibitor-2 en Espanol

Plasminogen activator inhibitor-2 en Francais

Businness

Plasminogen activator inhibitor-2 in the Marketplace

Patents on Plasminogen activator inhibitor-2

Experimental / Informatics

List of terms related to Plasminogen activator inhibitor-2

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Plasminogen activator inhibitor-2 (placental PAI) is a coagulation factor which inactivates tPA & urokinase. It is present in most cells, especially monocytes/macrophages. PAI-2 exists in two forms, a 60 kDa extracellular glycosylated form and a 43 kDa intracellular form.

Fibrinolysis (simplified). Blue arrows denote stimulation, and red arrows inhibition.
Fibrinolysis (simplified). Blue arrows denote stimulation, and red arrows inhibition.

It is only present at detectable quantities in blood during pregnancy, as it is produced by the placenta, and may explain partially the increased rate of thrombosis during pregnancy. The majority of expressed PAI-2 remains unsecreted due to the presence of an inefficient internal signal peptide.

See also

External links

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools